Shenzhen Wingor Biotechnology

Shenzhen Wingor Biotechnology is a clinical-stage biotechnology company specializing in the research, development, and industrialization of mesenchymal stem cell (MSC) therapies. Headquartered in Shenzhen, China, the company operates a comprehensive platform for cell storage, preparation, and clinical translation, adhering to international GMP standards. Its primary therapeutic focus includes regenerative medicine for orthopedic conditions, such as knee osteoarthritis, and chronic inflammatory diseases like liver cirrhosis. Wingor has successfully obtained multiple Investigational New Drug (IND) approvals from the National Medical Products Administration (NMPA). The company aims to provide standardized, high-quality cell products for precision medicine and healthy aging.